Patents/Assignees

Ionis Pharmaceuticals, Inc.

61 patents in portfolio

US11851655utility2023
Compositions and Methods for Modulating Apolipoprotein (a) Expression
0 cites
US11840686utility2023
Modulation of Prekallikrein (PKK) Expression
0 cites
US11840689utility2023
Method of Treating Fatty Liver Disease
0 cites
US11833221utility2023
Oligomeric Compounds for Reducing DMPK Expression
0 cites
US11834660utility2023
Compositions for Modulating Ataxin 2 Expression
0 cites
US11786546utility2023
Compounds and Methods for Modulating GFAP
0 cites
US11781143utility2023
Modulators of PNPLA3 Expression
0 cites
US11761000utility2023
Compositions and Their Uses Directed to Huntingtin
0 cites
US11753644utility2023
Compounds and Methods for Reducing IFNAR1 Expression
0 cites
US11732261utility2023
Selective Antisense Compounds and Uses Thereof
0 cites
US11732263utility2023
Compounds and Methods for Modulating PLP1
0 cites
US11732265utility2023
Compositions and Methods for Modulating Complement Factor B Expression
0 cites
US11725208utility2023
Conjugated Antisense Compounds and Their Use
0 cites
US11633483utility2023
Modulators of PCSK9 Expression
0 cites
US11634711utility2023
Methods and Compositions for Modulating Apolipoprotein (a) Expression
0 cites
US11629348utility2023
Linkage Modified Oligomeric Compounds and Uses Thereof
0 cites
US11613752utility2023
Compositions and Methods for Modulating PKK Expression
0 cites
US11583548utility2023
Compounds and Methods for Reducing ATXN3 Expression
0 cites
US11566245utility2023
Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof
0 cites
US11547718utility2023
Modulators of FOXP3 Expression
0 cites

← PreviousPage 3 of 4Next →